Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 12(1): 10595, 2022 06 22.
Article in English | MEDLINE | ID: mdl-35732649

ABSTRACT

Musa acuminata (MA) is a popular fruit peels in the world. Non-food parts of the plant have been investigated for their antioxidant and anti-ulcerative colitis activity. Metabolomic approaches were found to be informative as a screening tool. It discovered different metabolites depending on statistical analysis. The antioxidant activity content was measured by colorimetric method. Seventy six investigated metabolites were observed. The identities of some of these markers were confirmed based on their MS2 fragmentation and NMR spectroscopy. These include: cinnamic acid and its dimer 2-hydroxy-4-(4-methoxyphenyl)-1H-phenalen-1-one beside; gallic acid and flavonoids; quercetin, quercetin-3-O-ß-D-glucoside, luteolin-7-O-ß-D-glucopyranoside. GC/MS analysis of MA peels essential oil led to identification of 37 compounds. The leaves, pseudostem and fruit peels extracts were tested for their safety and their anti-ulcerative colitis efficacy in rats. Rats were classified into: normal, positive, prednisolone reference group, MA extracts pretreated groups (250-500 mg/kg) for 2 weeks followed by induction of ulcerative colitis by per-rectal infusion of 8% acetic acid. Macroscopic and microscopic examinations were done. Inflammatory markers (ANCA, CRP and Ilß6) were measured in sera. The butanol extracts showed good antioxidant and anti-inflammatory activities as they ameliorated macroscopic and microscopic signs of ulcerative colitis and lowered the inflammatory markers compared to untreated group. MA wastes can be a potential source of bioactive metabolites for industrial use and future employment as promising anti-ulcerative colitis food supplements.


Subject(s)
Colitis, Ulcerative , Musa , Animals , Antioxidants/pharmacology , Antioxidants/therapeutic use , Colitis, Ulcerative/drug therapy , Plant Extracts/chemistry , Quercetin/therapeutic use , Rats
2.
J Pharm Biomed Anal ; 201: 114139, 2021 Jul 15.
Article in English | MEDLINE | ID: mdl-34000580

ABSTRACT

Baobab fruit pulp Adansonia digitata (AD) has received attention due to its numerous nutritional and medicinal values. In the current study, tentative identification was performed due to limited information available on its phytochemical composition. Phytochemicals from AD fruit pulp were obtained using successive organic solvent fractionation. The LC-MSMS analysis led to identification of 91 metabolites from methanol, butanol and ethyl acetate extracts. Moreover, 20 compounds were identified in the petroleum ether extract based on high resolution ion masses. In vitro antidiabetic and antioxidant properties of selected extracts were investigated using enzyme activity and the 2,2-diphenyl-1-picrylhydrazyl (DPPH) method, respectively. Biological screening of the antidiabetic effects of target extracts was performed against streptozotocin-induced diabetes in experimental animals, following daily oral treatment for 3 successive weeks. Serum glucose, insulin, adiponectin, superoxide dismutase (SOD), lipid peroxide, cholesterol and HDL levels were measured. Finally, histopathological and immunohistochemical examinations of pancreas were carried out. Results revealed that animal groups treated daily with butanol (BuOH) and petroleum ether extracts of AD (oil) exhibited a significant improvement in carbohydrate and lipid metabolism as well as antioxidant effect. Both extracts revealed superior effects with respect to the total (TT) and ethyl acetate (EtOAc) extracts. Histopathological and immunohistochemical findings supported these results, showing marked protection of the pancreas. Thus, baobab oil and butanolic extract of the fruit pulp protected animals against STZ-induced diabetic changes, in addition to attenuation of lipid peroxidation, hypercholesterolemia and oxidation.


Subject(s)
Adansonia , Diabetes Mellitus, Experimental , Animals , Antioxidants/pharmacology , Diabetes Mellitus, Experimental/drug therapy , Fruit , Lipidomics , Plant Extracts/pharmacology , Rats
3.
J Diet Suppl ; 13(4): 378-92, 2016.
Article in English | MEDLINE | ID: mdl-26634867

ABSTRACT

The role of Physalis peruviana (golden berry) as functional food against hepato-renal fibrosis induced by carbon tetrachloride (CCl4) was evaluated. The chemical composition of leaves referred the presence of withanolides and flavonoids. Two compounds, ursolic acid and lupeol, were isolated and their structures were elucidated by different spectral analysis techniques. The biological evaluation was conducted on different animal groups; control rats, control orally treated with plant extract (500 mg/kg body weight twice a week for six consecutive weeks), CCl4 (0.5 ml/kg body weight diluted to 1:9 (v/v) in olive oil and injected intraperitoneally) group, CCl4 treated with plant extract and CCl4 treated with silymarin as a reference herbal drug. The evaluation was done through measuring oxidative stress markers; malondialdehyde (MDA), superoxide dismutase (SOD) and nitric oxide (NO). Liver function indices; aspartate and alanine aminotransferases (AST & ALT), alkaline phosphatase (ALP), gamma glutamyl transferase (GGT), bilirubin and total hepatic protein were also estimated. Kidney disorder biomarkers; creatinine, urea and serum protein were also evaluated. The results revealed plant safety and decrease in NO, MDA, IgG, ALP, tissue protein, bilirubin, creatinine and urea levels. Increase in SOD, AST, ALT, GGT and serum protein levels were observed. Improvement in liver and kidney histopathological architectures were also seen. In conclusion, Physalis peruviana recorded a significant protective role in liver and kidney against fibrosis. Further studies are needed to evaluate its isolated compounds and its use in pharmacological applications and clinical uses.


Subject(s)
Fibrosis/drug therapy , Functional Food/analysis , Kidney/drug effects , Liver/drug effects , Physalis/chemistry , Plant Leaves/chemistry , Alanine Transaminase/blood , Alkaline Phosphatase/blood , Animals , Antioxidants/analysis , Antioxidants/pharmacology , Aspartate Aminotransferases/blood , Bilirubin/blood , Biomarkers/blood , Carbon Tetrachloride/toxicity , Creatinine/blood , Fibrosis/chemically induced , Flavonoids/analysis , Flavonoids/pharmacology , Kidney/metabolism , Liver/metabolism , Male , Malondialdehyde/metabolism , Nitric Oxide/metabolism , Oxidative Stress/drug effects , Pentacyclic Triterpenes/analysis , Pentacyclic Triterpenes/pharmacology , Plant Extracts/analysis , Plant Extracts/pharmacology , Rats , Rats, Wistar , Superoxide Dismutase/metabolism , Triterpenes/analysis , Triterpenes/pharmacology , Withanolides/analysis , Withanolides/pharmacology , gamma-Glutamyltransferase/blood , Ursolic Acid
4.
J Diet Suppl ; 10(4): 357-69, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24168372

ABSTRACT

The aim of the present work is to investigate the potential of Physalis peruviana fruits as a hepatorenal protective agent against carbon tetrachloride (CCl4)-induced hepatic and renal fibrosis. The phytochemical screening test revealed the presence of alkaloids, free withanolides, glycowithanolides, and flavonoids. Acute toxicity study (500, 1000, and 1500 mg/kg body weight) revealed extract safety. The biological evaluation was conducted on different animal groups: control, control treated with fruit, CCl4 group, CCl4 treated with fruit, and CCl4 treated with silymarin drug. The evaluation was done through measuring oxidative stress markers: malondialdehyde (MDA), superoxide dismutase (SOD), and nitric oxide (NO). Liver function indices such as aspartate and alanine aminotransferases (AST & ALT), alkaline phosphatase (ALP), gamma glutamyl transferase (GGT), bilirubin, and total protein were estimated. Kidney disorder biomarkers such as creatinine, urea, and serum protein were also evaluated. Treatment improved all the investigated parameters, and the histopathological analysis confirmed our results. In conclusion, Physalis peruviana fruit succeeded to protect liver and kidney against fibrosis. Further studies are needed to identify the molecules responsible for its pharmacological application.


Subject(s)
Antioxidants/therapeutic use , Chemical and Drug Induced Liver Injury/drug therapy , Kidney Diseases/drug therapy , Kidney/drug effects , Liver/drug effects , Physalis/chemistry , Phytotherapy , Alkaloids/analysis , Alkaloids/pharmacology , Alkaloids/therapeutic use , Animals , Antioxidants/analysis , Antioxidants/pharmacology , Beverages , Bilirubin , Biomarkers/blood , Carbon Tetrachloride , Chemical and Drug Induced Liver Injury/metabolism , Chemical and Drug Induced Liver Injury/pathology , Fibrosis/drug therapy , Flavonoids/analysis , Flavonoids/pharmacology , Flavonoids/therapeutic use , Fruit/chemistry , Kidney/metabolism , Kidney Diseases/metabolism , Kidney Diseases/pathology , Lipid Peroxidation/drug effects , Liver/metabolism , Male , Malondialdehyde/blood , Oxidative Stress/drug effects , Plant Preparations/pharmacology , Plant Preparations/therapeutic use , Rats , Rats, Wistar , Severity of Illness Index , Withanolides/analysis , Withanolides/pharmacology , Withanolides/therapeutic use
5.
J Diet Suppl ; 10(1): 39-53, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23419022

ABSTRACT

This study was designed to investigate the potential of Physalis peruviana root as a functional food with hepato-renal protective effects against fibrosis. The chemical composition of the plant root suggested the presence of alkaloids, withanolides and flavonoids. Five compounds were isolated and their structures elucidated by different spectral analysis techniques. One compound was isolated from the roots: cuscohygrine. The biological evaluation was conducted on different animal groups; control rats, control treated with ethanolic root extract, CCl(4) group, CCl(4) treated with root extract, and CCl(4) treated with silymarin as a standard herbal drug. The evaluation used the oxidative stress markers malondialdehyde (MDA), superoxide dismutase (SOD), and nitric oxide (NO). The liver function indices; aspartate and alanine aminotransferases (AST & ALT), alkaline phosphatase (ALP), gamma glutamyl transferase (GGT), bilirubin, and total hepatic protein were also estimated. Kidney disorder biomarkers; creatinine, urea, and serum protein were also evaluated. The results suggested safe administration, and improvement of all the investigated parameters. The liver and kidney histopathological analysis confirmed the results. In conclusion, P. peruviana succeeded in protecting the liver and kidney against fibrosis. Further studies are needed to discern their pharmacological applications and clinical uses.


Subject(s)
Acetone/analogs & derivatives , Chemical and Drug Induced Liver Injury/prevention & control , Kidney Diseases/prevention & control , Kidney/drug effects , Liver/drug effects , Physalis/chemistry , Phytotherapy , Pyrrolidines/therapeutic use , Acetone/isolation & purification , Acetone/pharmacology , Acetone/therapeutic use , Animals , Biomarkers/metabolism , Carbon Tetrachloride , Chemical and Drug Induced Liver Injury/metabolism , Chemical and Drug Induced Liver Injury/pathology , Fibrosis/prevention & control , Functional Food , Kidney/metabolism , Kidney/pathology , Kidney Diseases/metabolism , Kidney Diseases/pathology , Liver/metabolism , Liver/pathology , Male , Oxidative Stress/drug effects , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Plant Roots/chemistry , Pyrrolidines/isolation & purification , Pyrrolidines/pharmacology , Rats , Rats, Wistar , Silymarin/therapeutic use
6.
J Ethnopharmacol ; 108(2): 236-42, 2006 Nov 24.
Article in English | MEDLINE | ID: mdl-16815658

ABSTRACT

Momordica charantia L. (MC) (Cucurbitaceae) commonly known as balsam pear, bitter gourd or karela, used in several purposes in traditional medicine is an important medicinal plant. Two sets of experiments were carried out, the first experiment indicated that the LD(50) for MC juice and alcoholic extracts were 91.9 and 362.34 mg/100g b.wt., respectively, of subcutaneously "s.c." injected mice. The toxic signs were recorded within the first 24 h post-injection. The second experiment was performed to evaluate the effect of MC juice and alcoholic extracts on blood glucose and other biochemical parameters in normal and diabetic rats. Both extracts induced a significant decrease in serum glucose levels in normal and diabetic rats. The two extracts did not show any significant effect in urea, creatinine, ALT, AST and AP in normal rat, while in diabetic rats the two extracts caused a significant decrease in serum urea, creatinine, ALT, AST, AP, cholesterol and triglyceride levels. Also, these results suggested that MC extracts possesses anti-diabetic, hepato-renal protective and hypolipidemic effect in alloxan-induced diabetic rats. Thus, MC is alternative therapy that has primarily been used for lowering blood glucose levels in patients with diabetes mellitus.


Subject(s)
Diabetes Mellitus, Experimental/prevention & control , Momordica charantia/chemistry , Plant Extracts/therapeutic use , Administration, Oral , Alkaline Phosphatase/blood , Alloxan , Animals , Anticholesteremic Agents/isolation & purification , Anticholesteremic Agents/therapeutic use , Anticholesteremic Agents/toxicity , Beverages , Blood Glucose/metabolism , Cholesterol/blood , Creatinine/blood , Diabetes Mellitus, Experimental/blood , Diabetes Mellitus, Experimental/chemically induced , Dose-Response Relationship, Drug , Ethanol , Female , Fruit , Hypoglycemia/blood , Hypoglycemia/chemically induced , Injections, Subcutaneous , Liver/drug effects , Liver/metabolism , Liver/pathology , Male , Plant Extracts/chemistry , Plant Extracts/toxicity , Rats , Rats, Sprague-Dawley , Transaminases/blood , Triglycerides/blood , Weight Gain/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...